Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The “Ig lambda chain V-I region pseudogene” (ENSG00000249333) is a noncoding genetic sequence found within the immunoglobulin lambda light chain gene locus. Immunoglobulin lambda chains are one of the two classes of antibody light chains in humans and play a critical role in the formation of antigen-binding sites. However, this specific gene is a pseudogene, meaning it contains mutations or sequence defects that prevent it from encoding a functional immunoglobulin protein. Pseudogenes in this locus often arise from gene duplication and recombination events but are generally not expressed or simply produce nonfunctional RNA transcripts. This pseudogene lacks disease relevance, known biological function, and established therapeutic interaction. The name may be confusing for therapeutic research, as only functional immunoglobulin genes or proteins are considered valid biological targets[1][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ig lambda chain V-I region pseudogene.